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People who use and inject drugs are among the groups at 
highest risk of acquiring HIV, yet remain marginalized and 
unable to access health and social services.  
In 2019,  
10% 
of all new HIV  
infections  
were among people  
who inject drugs (1).
OVERVIEW 
Evidence shows that 
new HIV infections drop 
sharply when drug use and 
possession for personal 
use is decriminalized and 
people who inject drugs 
have access to harm 
reduction and other public 
health programmes, and 
stigma, discrimination 
and marginalization are 
reduced (2).
People who inject drugs, including 
people in prisons and other closed 
settings, have a right to equal 
enjoyment of the highest attainable 
standard of health, including the 
right to harm reduction services to 
prevent HIV and other bloodborne 
infections, including needle–





and management  
(2, 3, 4).
Women make up a small but 
significant proportion of people who 
inject drugs, usually between
10% AND 30% (5).
 
Data indicate that women who 
inject drugs are more likely than 
male peers to be living with HIV 
and face higher rates of conviction/
incarceration, yet they face 
particular challenges  
in accessing harm reduction 
services tailored to their needs 
and higher levels of stigma and 
discrimination (2).
Punitive drug control laws, policies and law enforcement practices have been 
shown to be among the largest obstacles to health care in many countries, 
along with financing and political will (6, 7). A rights-based approach to drug 
policy, including decriminalization of drug use and possession for personal 
use and reducing stigma and discrimination can improve access to health 
care, harm reduction and legal services and reduces broader inequalities.
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THE DATA
In 2019, the risk of acquiring HIV was  
29 times higher




people who inject drugs 
are living with HIV (8). 
Prevalence of hepatitis C is also high. Modelling suggests that 43% of new 
hepatitis C infections could be prevented between 2018 and 2030 if risk of 
transmission through injecting drug use is removed (9).
10% of new 
HIV infections
in 2019 were among 
people who inject drugs. 
In some regions, such 
as Asia and the Pacific, 
eastern Europe and 
central Asia, Middle 
East and North Africa 
and western and central 
Europe and North 
America this proportion is 
even higher (1).
New HIV infections among people  
of all ages worldwide declined by 23%  
between 2010–2019, but there is no evidence 
of a change in global incidence among 
people who inject drugs—and in some 
regions incidence has increased (1, 10).
?Among people who inject drugs, on average38.1%  
do not know their HIV status (1).
Lack of consistently available and robust data on 
prevention, testing and treatment hinder efforts to 
improve service access for people who inject drugs.
Although some countries have dramatically reduced new HIV 
infections through effective harm reduction including needle and 
syringe programmes and opioid substitution therapy, less than  
of people who inject drugs live in countries with the 
UN-recommended levels of coverage of needles, 
syringes and opioid substitution therapy (2). 
1%
Less than half of men who inject 
drugs were able to access at least 
two HIV prevention services  
in the past three months 
in 10 of 14 reporting 
countries (1).
Rates of intimate partner and 
gender-based violence are up to five 
times higher among women who 
inject drugs compared 
with women who do 
not inject drugs (11). 5x
Approximately 11 million people are 
in prison on any one day. 2.2 million  
are in prison, sentenced 
for drug-related crimes, 
22% of whom are serving 
a sentence for drug 
possession (12, 13). 
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LINKING RIGHTS AND 
HEALTH OUTCOMES
Criminalization of 
drug use and harsh 
punishments (such as 
incarceration) discourage 
uptake of HIV services, 
drive users underground 
and lead to unsafe 
practices (14). 
A systematic study in  
2017 found that 
MORE THAN 80% 
of  published studies found 
criminalization to have a negative effect 
on HIV prevention and treatment. 
Decriminalization of drug use 
and possession for personal 
use is associated with 
significant decreases in HIV 
incidence among people who 
inject drugs, including through 
greater access to harm reduction 
services, reductions in violence 
and arrest or harassment by law 







Less than 10% of countries criminalize drug use and 
possession of small amounts of drugs.
Less than 10% of people who use drugs report experiencing 
stigma and discrimination. 
Less than 10% of people who use drugs lack mechanisms for 
people living with HIV and key populations to report abuse 
and discrimination and seek redress.
Less than 10% of people who use drugs lack access to 
legal services. 
Less than 10 % of health workers and law enforcement officers 
report negative attitudes toward people who use drugs.
Less than 10% of people who use drugs experience physical or 
sexual violence. 
A 2019 systematic review found that repressive policing of 
drug use was associated with HIV infection, needle sharing 
and avoidance of harm reduction programmes (7).
Czechia, Netherlands, 
Portugal and Switzerland are 
among a handful of countries that 
have decriminalized drug use and 
possession for personal use or 
have diversion policies in place. 
They have also financially invested 
in harm reduction. The number of 
new HIV diagnoses among people 
who inject drugs in these countries 
is low (15). For example, in both 
Czechia and the Netherlands the 
annual number of new cases has 
been under twelve in the years 
2009–2018.




Criminalization of drug use 
and possession for personal 
use affects the realization of 
the right to health (3, 17, 18). 
INTERNATIONAL DRUG 
CONVENTIONS 
are subject to and must be interpreted in 
line with international human rights 
obligations (16).
People who use 
drugs have a 
right to access 
the comprehensive 
package of HIV 
and harm reduction services, as 
developed by WHO, United Nations 
Office on Drugs and Crime (UNODC) 
and UNAIDS, including needle 
and syringe programmes, opioid 
substitution therapy and naloxone 
to prevent overdose (2). This has 
been endorsed at various times by 
the UN General Assembly (27), the 
Commission on Narcotic Drugs (28, 
29) and the Economic and Social 
Council (30). It is necessary for the 
enjoyment of the right to health (31, 
32), the right to life (33), to non-
discrimination (19) and to ensure that 
people who use drugs may equally 
benefit from scientific progress and its 
applications (34). UN agencies have 
also recommended the provision of 
safe consumption rooms (2).
States have an obligation to 
protect people who use drugs from 
discrimination and stigma (19). 
People who use drugs have a right 
to participate in the development, 
implementation and monitoring of 
any policy or intervention that affects 
them (35). The UN General Assembly 
has made it clear that communities 
should be enabled to play this role (36).
States have an obligation, under the 
rights to health, life and enjoyment of 
scientific advances, to take legislative 
and other appropriate measures to 
ensure that scientific knowledge and 
technologies and their applications—
including evidence-based, 
scientifically proven interventions to 
treat drug dependence, to prevent 
overdose and to prevent, treat and 
control HIV, hepatitis C and other 
diseases—are physically available 
and financially accessible without 
discrimination (3, 37–39). 
Treatment should be voluntary, non-discriminatory, acceptable,  
of good quality and accessible, including in prisons at 
a standard equivalent to 
that in the community(3, 40).
States should refrain from 
conditioning welfare benefits on drug 
testing which is unreasonable and 
disproportionate. States should cease 
the practice of random drug tests in 
schools, which are ineffective and a 





have been found to breach 
international human rights 
obligations, including the right 
to health, freedom from arbitrary 
arrest and detention and to be free 
from torture and cruel, inhuman and 
degrading treatment. Human rights 
bodies, experts and UN agencies 
have called for their immediate 
closure (37, 42–44).
The death penalty should not be 
used for drug offences. International 
law states that if countries have 
not abolished the death penalty, it 
should be reserved only for the most 
serious crimes involving intentional 
killing (3, 33).
States should provide gender-
responsive interventions that 
incorporate the needs of women into 
their design and implementation, 
including addressing the sexual and 
reproductive health needs of women 
who use drugs (2).
United Nations (UN) human rights bodies and experts and all UN agencies 
have recommended decriminalization of possession of drugs for personal use 
as a key element in fulfilling the right to health and reducing HIV incidence 
(19–23). The World Health Organization (WHO) specifically called for the 
decriminalization of drug use and possession for personal use as a key element 
in reducing HIV incidence among people who inject drugs (4, 14, 24–26).
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KEY RESOURCES FOR FURTHER INFORMATION
• International Centre on Human Rights and Drug Policy, UNAIDS, WHO, United Nations Development Programme (UNDP), 
International Guidelines on Human Rights and Drug Policy, 2019 
• UNAIDS, Health, Rights and Drugs: Harm Reduction, Decriminalization and Zero Discrimination for People Who Use Drugs, 2019 
• Global Commission on HIV and the Law, Risks, Rights & Health, 2012 and 2018 Supplement
• UN Chief Executives Board for Coordination, United Nations System Common Position Supporting the Implementation of 
the International Drug Control Policy through Effective Inter-Agency Collaboration, 2018 
• West African Commission on Drugs, Model Drug Law for West Africa: A Tool for Policymakers, 2018
• International Network of People Who Use Drugs (INPUD), Drug Decriminalisation: Progress or Political Red Herring? 2021 
This policy brief is produced by UNAIDS as a reference on HIV human rights and people who use drugs. It does not 
include all recommendations and policies relevant to the issue covered. Please refer to the key resources listed above 
for further information.
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